ROBINSON LOWELL W

Director Robinson Lowell W buys 130 shares at $48.15 avg; stock down 11.4% from 52-week high amid -$1.5M net income.

Director Robinson Lowell W executed 2 purchases totaling 130 shares for $6,259.18 on September 16–17, 2025, at a blended average price of $48.15, raising his holdings from 2,870 to 3,000 shares (+4.5%). The purchases occurred while PhenixFIN stock trades at $48.20, down 11.4% from its 52-week high of $54.38 and off 2.7% over 30 days. The company reported net income of -$1,497,463.00, indicating operating losses that weigh on fundamental support. Robinson's cross-ticker track record shows 16 prior buys with a 100.00% 90-day win rate and an average 90-day return of +1.3%, but this represents broad market experience; his prior 5 trades at PFX (all buys on September 5, 9–12) have no measurable 90-day outcomes yet, offering no precedent for timing accuracy at this ticker. The sale of only 130 shares against depressed fundamentals and recent price weakness reflects a modest accumulation stance rather than a material conviction signal.

Director Robinson Lowell W bought 262 shares at $48.07 blended average; 5 prior PFX purchases in 10 days signal sustained accumulation.

Robinson Lowell W, a director at PhenixFIN, executed 2 separate purchases totaling 262 shares for $12,593.10 on 2025-09-11 and 2025-09-12, expanding holdings by 10.0% to 2,870 shares. This filing reflects part of a broader buying pattern: he has completed 5 distinct open-market purchases at PFX over 10 trading days (2025-08-20 through 2025-09-12), indicating sustained interest in accumulating shares at current levels near $48. His cross-ticker track record shows 14 prior buys with a 100.00% 90-day win rate and an average 90-day return of 1.3%, though outcomes on these recent same-ticker purchases are not yet measurable. The company trades at a P/E of 6.02 against a negative net income of $-1.5M and a market cap of $96.1M, presenting a distressed-valuation backdrop to these purchases.

Director Robinson Lowell W bought 284 shares across 2 transactions at avg $48.16, now holds 2,608 shares (+12.2%)

Robinson Lowell W (Director) made 2 purchases totaling 284 shares for $13,676.20 on 2025-09-09 and 2025-09-10 at a blended average price of $48.16. His holdings increased 12.2% to 2,608 shares post-transaction. The current price of $47.95 sits 11.8% below the 52-week high and the transactions occurred as the stock was relatively stable over 90 days (-0.1%). Across his cross-ticker open-market history, Robinson has 13 prior buys with a 100% 90-day win rate and average 90-day return of +1.3%, but his 5 prior trades at PFX are all recent (August–September 2025) with outcomes not yet measurable. The company reported net income of -$1,497,463.00, and the P/E of 6.02 reflects distress metrics. This buying pattern—accumulation across multiple dates at a relatively stable price point—continues a recent sequence at this ticker without yet providing a track record of timing outcomes.

Director Robinson Lowell W bought 149 shares at blended average $48.20 on PFX; holdings now 2,324 shares (+6.9%).

Director Robinson Lowell W made 2 separate purchases totaling 149 shares for $7,182.35 on September 3–5, 2025, increasing his holdings by 6.9% to 2,324 shares. His cross-ticker track record shows 10 prior buys with a 100% win rate at the 90-day mark, though his prior 5 purchases at PFX (all in mid-August 2025) are too recent to show measurable outcomes. The current price of $48.12 is -11.5% from the 52-week high of $54.38 and the stock has declined 2.1% over 30 days, creating a modest drawdown context for the buys. The company reports negative net income of $-1,497,463.00 and trades at a P/E of 6.04 on a $96.4M market cap, indicating structural unprofitability that tempers the signal strength of open-market accumulation.

Director Robinson Lowell W bought 264 shares of PFX in two transactions (189 shares at $49.25, 75 shares at $49.28) for $13,004.25 total.

Director Robinson Lowell W executed two separate purchases totaling 264 shares for $13,004.25 over two consecutive trading days (2025-08-19 and 2025-08-20), increasing his holdings by 13.8% from 1,911 to 2,175 shares. The purchases occurred near the current price of $49.24, well below the 52-week high of $54.38. His cross-ticker track record shows 8 prior buys with a 100.00% 90-day win rate and +10.9% average 30-day return, though his five most recent trades at PFX (all buys within the past week) have not yet accumulated measurable outcomes. The company reported a net loss of $1,497,463.00 and carries a P/E of 6.18 despite a $98.7M market cap, presenting a contrasting picture of director accumulation amid negative earnings.

Director Robinson buys 247 shares across 3 trades (Aug 14–18) at blended $48.95; holdings jump 14.8% to 1,911 shares.

Robinson Lowell W, a Director at PhenixFIN Corp, executed 3 separate purchases totaling 247 shares for $12,090.19 at prices ranging from $48.87 to $49.03 between August 14–18, 2025. This represents a 14.8% increase in his holdings relative to the pre-transaction base of 1,664 shares. The purchases occurred near the current trading price of $49.03, which sits -9.8% below the 52-week high of $54.38, and follow a recent pattern of insider buying at PFX: Robinson has also purchased shares on August 12, August 11, and August 8 of this same month, though outcomes on those recent trades are not yet measurable. His prior two purchases at PFX (February 12 and 11, 2025) each delivered positive 30-day and 90-day returns, with a 100% timing success rate across that pair. The company's fundamentals show a negative net income of -$1,497,463.00, which warrants attention in the context of ongoing insider accumulation.

Director Robinson Lowell W bought 164 shares across 3 trades (Aug 8–12) at $49.11 avg, increasing stake 10.9% to 1,664 shares.

Robinson Lowell W, a PhenixFIN Corp director, executed 3 separate open-market purchases totaling 164 shares for $8,053.81 between August 8 and 12, 2025, at a blended average price of $49.11 per share. This increased his holdings by 10.9%, from 1,500 to 1,664 shares, during a period when the stock was trading near the low end of its 52-week range ($45.01–$54.38) and down 9.6% from its recent high. His cross-ticker track record shows 2 prior buys with positive 90-day outcomes (100% win rate, averaging +1.3% over 90 days), and at this same ticker his prior 2 buys (Feb 11–12, 2025) were both well-timed on the 90-day basis. The company is unprofitable (net income: $-1,497,463.00) with a P/E of 6.16 and market cap of $98,450,083.97. The pattern of deliberate accumulation at suppressed valuations, combined with his track record of successful prior trades at this ticker, merits attention from investors monitoring insider activity and management conviction.

Director Lowell Robinson buys 500 shares at $48.81 avg, increasing holdings 50% to 1,500 shares

Lowell Robinson, a PhenixFIN director, executed 2 separate purchases totaling 500 shares for $24,405.65 on consecutive trading days (February 11-12, 2025), at prices of $48.79 and $48.90 respectively, with a blended average of $48.81. This purchase increased his holdings from 1,000 shares to 1,500 shares—a 50% increase in his position. The current stock price of $49.05 sits near the transaction prices, suggesting the director purchased at current market levels rather than at a significant discount or premium. With a P/E of 4.90 and positive net income of $2,464,157.00, the company trades at a modest valuation multiple. The director's decision to accumulate shares across two consecutive days merits scrutiny regarding any underlying factors driving the purchase, though the filing itself does not provide explicit motivation or context for the timing of these acquisitions.